General Information of This Antigen
Antigen ID
TAR0QHRAZ
Antigen Name
Leukocyte surface antigen CD47 (CD47)
Gene Name
CD47
Synonym
MER6; Antigenic surface determinant protein OA3;Integrin-associated protein;Protein MER6;CD_antigen=CD47
Sequence
MWPLVAALLLGSACCGSAQLLFNKTKSVEFTFCNDTVVIPCFVTNMEAQNTTEVYVKWKF
KGRDIYTFDGALNKSTVPTDFSSAKIEVSQLLKGDASLKMDKSDAVSHTGNYTCEVTELT
REGETIIELKYRVVSWFSPNENILIVIFPIFAILLFWGQFGIKTLKYRSGGMDEKTIALL
VAGLVITVIVIVGAILFVPGEYSLKNATGLGLIVTSTGILILLHYYVFSTAIGLTSFVIA
ILVIQVIAYILAVVGLSLCIAACIPMHGPLLISGLSILALAQLLGLVYMKFVASNQKTIQ
PPRKAVEEPLNAFKESKGMMNDE

    Click to Show/Hide
Function
Adhesive protein that mediates cell-to-cell interactions. Acts as receptor for thrombospondin THBS1 and as modulator of integrin signaling through the activation of heterotrimeric G proteins. Involved in signal transduction, cardiovascular homeostasis, inflammation, apoptosis, angiogenesis, cellular self- renewal, and immunoregulation. Plays a role in modulating pulmonary endothelin EDN1 signaling. Modulates nitrous oxide (NO) signaling, in response to THBS1, hence playing a role as a pressor agent, supporting blood pressure. Plays an important role in memory formation and synaptic plasticity in the hippocampus. Receptor for SIRPA, binding to which prevents maturation of immature dendritic cells and inhibits cytokine production by mature dendritic cells. Interaction with SIRPG mediates cell-cell adhesion, enhances superantigen-dependent T-cell-mediated proliferation and costimulates T-cell activation. Positively modulates FAS-dependent apoptosis in T-cells, perhaps by enhancing FAS clustering. Plays a role in suppressing angiogenesis and may be involved in metabolic dysregulation during normal aging. In response to THBS1, negatively modulates wound healing. Inhibits stem cell self-renewal, in response to THBS1, probably by regulation of the stem cell transcription factors POU5F1/OCT4, SOX2, MYC/c-Myc and KLF4. May play a role in membrane transport and/or integrin dependent signal transduction. May prevent premature elimination of red blood cells.

    Click to Show/Hide
Uniprot Entry
CD47_HUMAN
HGNC ID
HGNC:1682
KEGG ID
hsa:961
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
ADC Info ADC Name Payload Target Linker Ref
40187444 7DC2-DM1
Mertansine DM1
Undisclosed
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
[1]
ADC Info ADC Name Payload Target Linker Ref
40187444 7DC4-DM1
Mertansine DM1
Undisclosed
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
[1]
Anti-CD47 ALTA-002 mAb
ADC Info ADC Name Payload Target Linker Ref
ALTA-002
Differentiated TLR-9 agonist (T-CpG)
Undisclosed
Undisclosed
Anti-CD47 mAb (IgG2b/kappa)-
ADC Info ADC Name Payload Target Linker Ref
Anti-CD47 mAb (IgG2b/kappa)-DM1
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
[2]
Humanized anti-CD47 IgG1 mAb
ADC Info ADC Name Payload Target Linker Ref
SGN-CD47M
Monomethyl auristatin E
Undisclosed
Metalloproteinases cleavable linker
ADC Info ADC Name Payload Target Linker Ref
CD47-LLO
Listeriolysin O
Undisclosed
Undisclosed
[3]
Undisclosed
ADC Info ADC Name Payload Target Linker Ref
YB1-ADC-CD47
Undisclosed
Undisclosed
Undisclosed
[4]
undisclosed
ADC Info ADC Name Payload Target Linker Ref
ATICC
Trojan TLR7/8a
Undisclosed
Undisclosed
[5]
References
Ref 1 Generation and characterization of 7DC-DM1: a non-cleavable CD47-targeting antibody-drug conjugates with antitumor effects
Ref 2 Anti-CD47 Monoclonal Antibody-Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers. Vaccines (Basel). 2021 Aug 10;9(8):882. doi: 10.3390/vaccines9080882.
Ref 3 An antibody-toxin conjugate targeting CD47 linked to the bacterial toxin listeriolysin O for cancer immunotherapy
Ref 4 YB1 pharmaceutical company product pipeline
Ref 5 Bioconjugated Antibody-Trojan Immune Converter Enhance Cancer Immunotherapy with Minimized Toxicity by Programmed Two-Step Immunomodulation of Myeloid Cells